Cargando…

Neural progenitor cells from an adult patient with fragile X syndrome

BACKGROUND: Currently, there is no adequate animal model to study the detailed molecular biochemistry of fragile X syndrome, the leading heritable form of mental impairment. In this study, we sought to establish the use of immature neural cells derived from adult tissues as a novel model of fragile...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Philip H, Tassone, Flora, Greco, Claudia M, Nethercott, Hubert E, Ziaeian, Boback, Hagerman, Randi J, Hagerman, Paul J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545950/
https://www.ncbi.nlm.nih.gov/pubmed/15649335
http://dx.doi.org/10.1186/1471-2350-6-2
_version_ 1782122222849097728
author Schwartz, Philip H
Tassone, Flora
Greco, Claudia M
Nethercott, Hubert E
Ziaeian, Boback
Hagerman, Randi J
Hagerman, Paul J
author_facet Schwartz, Philip H
Tassone, Flora
Greco, Claudia M
Nethercott, Hubert E
Ziaeian, Boback
Hagerman, Randi J
Hagerman, Paul J
author_sort Schwartz, Philip H
collection PubMed
description BACKGROUND: Currently, there is no adequate animal model to study the detailed molecular biochemistry of fragile X syndrome, the leading heritable form of mental impairment. In this study, we sought to establish the use of immature neural cells derived from adult tissues as a novel model of fragile X syndrome that could be used to more fully understand the pathology of this neurogenetic disease. METHODS: By modifying published methods for the harvest of neural progenitor cells from the post-mortem human brain, neural cells were successfully harvested and grown from post-mortem brain tissue of a 25-year-old adult male with fragile X syndrome, and from brain tissue of a patient with no neurological disease. RESULTS: The cultured fragile X cells displayed many of the characteristics of neural progenitor cells, including nestin and CD133 expression, as well as the biochemical hallmarks of fragile X syndrome, including CGG repeat expansion and a lack of FMRP expression. CONCLUSION: The successful production of neural cells from an individual with fragile X syndrome opens a new avenue for the scientific study of the molecular basis of this disorder, as well as an approach for studying the efficacy of new therapeutic agents.
format Text
id pubmed-545950
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5459502005-01-28 Neural progenitor cells from an adult patient with fragile X syndrome Schwartz, Philip H Tassone, Flora Greco, Claudia M Nethercott, Hubert E Ziaeian, Boback Hagerman, Randi J Hagerman, Paul J BMC Med Genet Technical Advance BACKGROUND: Currently, there is no adequate animal model to study the detailed molecular biochemistry of fragile X syndrome, the leading heritable form of mental impairment. In this study, we sought to establish the use of immature neural cells derived from adult tissues as a novel model of fragile X syndrome that could be used to more fully understand the pathology of this neurogenetic disease. METHODS: By modifying published methods for the harvest of neural progenitor cells from the post-mortem human brain, neural cells were successfully harvested and grown from post-mortem brain tissue of a 25-year-old adult male with fragile X syndrome, and from brain tissue of a patient with no neurological disease. RESULTS: The cultured fragile X cells displayed many of the characteristics of neural progenitor cells, including nestin and CD133 expression, as well as the biochemical hallmarks of fragile X syndrome, including CGG repeat expansion and a lack of FMRP expression. CONCLUSION: The successful production of neural cells from an individual with fragile X syndrome opens a new avenue for the scientific study of the molecular basis of this disorder, as well as an approach for studying the efficacy of new therapeutic agents. BioMed Central 2005-01-14 /pmc/articles/PMC545950/ /pubmed/15649335 http://dx.doi.org/10.1186/1471-2350-6-2 Text en Copyright © 2005 Schwartz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Advance
Schwartz, Philip H
Tassone, Flora
Greco, Claudia M
Nethercott, Hubert E
Ziaeian, Boback
Hagerman, Randi J
Hagerman, Paul J
Neural progenitor cells from an adult patient with fragile X syndrome
title Neural progenitor cells from an adult patient with fragile X syndrome
title_full Neural progenitor cells from an adult patient with fragile X syndrome
title_fullStr Neural progenitor cells from an adult patient with fragile X syndrome
title_full_unstemmed Neural progenitor cells from an adult patient with fragile X syndrome
title_short Neural progenitor cells from an adult patient with fragile X syndrome
title_sort neural progenitor cells from an adult patient with fragile x syndrome
topic Technical Advance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545950/
https://www.ncbi.nlm.nih.gov/pubmed/15649335
http://dx.doi.org/10.1186/1471-2350-6-2
work_keys_str_mv AT schwartzphiliph neuralprogenitorcellsfromanadultpatientwithfragilexsyndrome
AT tassoneflora neuralprogenitorcellsfromanadultpatientwithfragilexsyndrome
AT grecoclaudiam neuralprogenitorcellsfromanadultpatientwithfragilexsyndrome
AT nethercotthuberte neuralprogenitorcellsfromanadultpatientwithfragilexsyndrome
AT ziaeianboback neuralprogenitorcellsfromanadultpatientwithfragilexsyndrome
AT hagermanrandij neuralprogenitorcellsfromanadultpatientwithfragilexsyndrome
AT hagermanpaulj neuralprogenitorcellsfromanadultpatientwithfragilexsyndrome